Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2496163rdf:typepubmed:Citationlld:pubmed
pubmed-article:2496163lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:2496163lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:2496163lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:2496163lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:2496163lifeskim:mentionsumls-concept:C0040557lld:lifeskim
pubmed-article:2496163pubmed:issue9lld:pubmed
pubmed-article:2496163pubmed:dateCreated1989-5-31lld:pubmed
pubmed-article:2496163pubmed:abstractTextAfter peroral infection with cysts of Toxoplasma gondii, C57BL/6 mice died and A/J mice survived. To better understand the reasons for this difference in survival, host defenses during acute infection were studied: initial portal of entry of T. gondii contributed to susceptibility as more C57BL/6 mice survived after i.p. than peroral infection (p less than 0.001). Susceptible (C57BL/6) mice had more necrosis and inflammation in their brains, livers, and mesenteric lymph nodes than resistant (A/J) mice. Susceptible mice had less IgM antibody to T. gondii (p less than 0.0005) than resistant mice 7 days after infection, but amounts of IgG antibody to T. gondii were similar. Infection reduced percentages of spleen cells with the Lyt-2+ phenotype in susceptible (p less than 0.02) but not resistant mice; infection decreased percentages of spleen cells with the L3T4+ phenotype similarly in both strains of mice. Spleen cells from infected susceptible mice had greater depression in their blastogenic response to Con A (p less than 0.05) and produced significantly more IFN-gamma in culture with (p = 0.009) or without (p less than 0.05) Toxoplasma Ag than spleen cells from infected resistant mice. Infection increased serum levels of IFN-gamma substantially in susceptible but not resistant mice. Lymphocyte IL-2 production was similar in both groups of mice. Peritoneal macrophages from both strains of mice became activated to inhibit or kill T. gondii by 7 days after infection, but Kupffer cells became activated only in susceptible mice. These results indicate that increased resistance to peroral Toxoplasma infection is likely to be mediated by a number of immune responses acting together. They suggest that increased susceptibility may result from inadequately regulated inflammatory responses that increase tissue destruction.lld:pubmed
pubmed-article:2496163pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2496163pubmed:languageenglld:pubmed
pubmed-article:2496163pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2496163pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2496163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2496163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2496163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2496163pubmed:statusMEDLINElld:pubmed
pubmed-article:2496163pubmed:monthMaylld:pubmed
pubmed-article:2496163pubmed:issn0022-1767lld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:BrownCClld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:McLeodRRlld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:FiliceGGlld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:MackDDlld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:SpitalnyGGlld:pubmed
pubmed-article:2496163pubmed:authorpubmed-author:EisenhauerPPlld:pubmed
pubmed-article:2496163pubmed:issnTypePrintlld:pubmed
pubmed-article:2496163pubmed:day1lld:pubmed
pubmed-article:2496163pubmed:volume142lld:pubmed
pubmed-article:2496163pubmed:ownerNLMlld:pubmed
pubmed-article:2496163pubmed:authorsCompleteYlld:pubmed
pubmed-article:2496163pubmed:pagination3247-55lld:pubmed
pubmed-article:2496163pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:meshHeadingpubmed-meshheading:2496163-...lld:pubmed
pubmed-article:2496163pubmed:year1989lld:pubmed
pubmed-article:2496163pubmed:articleTitleImmune responses associated with early survival after peroral infection with Toxoplasma gondii.lld:pubmed
pubmed-article:2496163pubmed:affiliationDepartment of Medicine, Michael Reese Medical Center, Chicago, IL 60616.lld:pubmed
pubmed-article:2496163pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2496163pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2496163pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2496163lld:pubmed